Page last updated: 2024-08-21

hematoxylin and Cerebral Infarction, Middle Cerebral Artery

hematoxylin has been researched along with Cerebral Infarction, Middle Cerebral Artery in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Chen, J; Jiang, N; Luo, J; Yang, C; Yu, G; Zhao, J; Zhao, Y1
Cheng, H; Hua, Y; Seto, S; Wang, G; Wang, L; Wang, N; Wang, Y; Yuan, M; Zhang, Y1
Chen, W; Wan, H; Wang, X; Wang, Y; Yang, Y; Zhang, H; Zhu, Z1
Cao, GZ; Hou, JY; Tian, LL; Wang, LF; Wu, HW; Xu, H; Yang, HJ; Zhang, JJ; Zhang, Y; Zhou, R1
Huang, J; Lin, L; Lv, X; Shen, Y; Tang, W; Wang, B; Yao, Y1
Date, I; Hamada, H; Hirai, S; Honmou, O; Houkin, K; Ishii, K; Ito, Y; Kato, K; Kawano, Y; Kobune, M; Kurozumi, K; Nakamura, K; Sasaki, K; Tamiya, T; Uchida, H1
Cai, D; Chen, J; Hua, Q; Jia, X; Li, P; Shen, Y; Tang, H; Xu, Y; Zhu, X1

Other Studies

7 other study(ies) available for hematoxylin and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Inhibition of miR-423-5p Exerts Neuroprotective Effects in an Experimental Rat Model of Cerebral Ischemia/Reperfusion Injury.
    Neuroscience, 2022, 11-01, Volume: 503

    Topics: Animals; Apoptosis; Brain Ischemia; Eosine Yellowish-(YS); Hematoxylin; Infarction, Middle Cerebral Artery; Inflammasomes; Ischemic Stroke; MicroRNAs; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Reperfusion Injury; Water

2022
Study on the mechanism of Tong-Qiao-Huo-Xue decoction regulating apoptosis via ASK1/MKK4/JNK pathway in MCAO/R rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 106

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Drugs, Chinese Herbal; Eosine Yellowish-(YS); Hematoxylin; Infarction, Middle Cerebral Artery; MAP Kinase Signaling System; Molecular Docking Simulation; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Reperfusion Injury; RNA, Messenger

2022
Danhong injection alleviates cerebral ischemia-reperfusion injury by inhibiting autophagy through miRNA-132-3p/ATG12 signal axis.
    Journal of ethnopharmacology, 2023, Jan-10, Volume: 300

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Autophagy-Related Protein 12; Autophagy-Related Proteins; Brain Ischemia; Chlorides; Drugs, Chinese Herbal; Eosine Yellowish-(YS); Glucose; Hematoxylin; Infarction, Middle Cerebral Artery; MicroRNAs; Oxygen; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Reperfusion Injury; TOR Serine-Threonine Kinases

2023
Integrated transcriptomics and metabolomics analysis reveals that C3 and C5 are vital targets of DuZhi Wan in protecting against cerebral ischemic injury.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: Animals; Brain Ischemia; Cytokines; Eosine Yellowish-(YS); Glycerophospholipids; Hematoxylin; Infarction, Middle Cerebral Artery; Interleukin-6; Ischemia; Matrix Metalloproteinase 9; Metabolomics; Mice; Neuroprotective Agents; Purines; Reperfusion Injury; Transcriptome

2022
Neuroprotective Effect of Stroke Pretreated Mesenchymal Stem Cells Against Cerebral Ischemia/Reperfusion Injury in Rats.
    World neurosurgery, 2022, Volume: 165

    Topics: Animals; Apoptosis; Brain Ischemia; Cytokines; Disease Models, Animal; DNA Nucleotidylexotransferase; Eosine Yellowish-(YS); Hematoxylin; Infarction, Middle Cerebral Artery; Inflammation; Mesenchymal Stem Cells; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Serum Albumin, Bovine; Stroke

2022
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2005, Volume: 11, Issue:1

    Topics: Animals; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Eosine Yellowish-(YS); Genetic Therapy; Hematoxylin; Humans; Infarction, Middle Cerebral Artery; Male; Mesenchymal Stem Cells; Nerve Growth Factors; Rats; Rats, Wistar; Staining and Labeling; Tetrazolium Salts

2005
Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase.
    Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:4

    Topics: Animals; Blotting, Western; Brain; Brain Ischemia; Coloring Agents; Drugs, Chinese Herbal; Electrophoresis, Polyacrylamide Gel; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Immunohistochemistry; Infarction, Middle Cerebral Artery; Medicine, Chinese Traditional; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Stroke

2008